Start-Up Previews, July-August 2014
Executive Summary
This Month's Profile Groups: Biopharma In Sweden, features profiles of Northern Light Pharmaceuticals, Sigrid Therapeutics, and Swecure; ENT Devices features profiles of Aerin Medical, ENTvantage Diagnostics, Fiagon, and Spirox. Plus these Start-Ups Across Health Care: Anagnostics Bioanalysis, Check-Cap, Edico Genome, G1 Therapeutics, HeadSense Medical, Innovent Biologics, Navitor Pharmaceuticals, Onciomed, and RevMedx.
You may also be interested in...
RevMedx Inc.
RevMedx Inc. received FDA de novo approval in April for battlefield use of XStat, which treats noncompressible bleeding from internal wounds. The injectable sponges of XStat expand upon contact with blood to fill the wound cavity, thus creating a temporary barrier and providing hemostatic pressure until hospital care can be rendered.
Anagnostics Bioanalysis GMBH
Rather than waiting up to one full week to confirm suspected cases of sepsis through a routine blood test that uses conventional microbiologyi, the hyborg cylindrical microarray platform from Austria’s Anagnostics Bioanalysis GMBH delivers results in a mere four hours.
Fiagon AG Medical Technologies
The FlexPointer from Fiagon AG Medical Technologies is a surgical navigation system that calculates the correct position of the instrument in patients’ sinuses. It can be used in any part of any sinus, without the need to exchange navigational instruments during a procedure.